Cargando…

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma

PURPOSE: Gliomas, characterized by aggressiveness and invasiveness, remain incurable after conventional therapies. The molecular mechanisms driving the progression and maintenance of glioma are still poorly understood. METHODS: The TCGA and CGGA databases were chosen for bioinformatics analysis. Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Haoyu, Liu, Qing, Xiao, Kai, He, Zhengxi, Wu, Chao, Sun, Jianjun, Chen, Xin, Chen, Suhua, Yang, Jun, Ma, Qianquan, Su, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802790/ https://www.ncbi.nlm.nih.gov/pubmed/33447054 http://dx.doi.org/10.2147/OTT.S287931

Ejemplares similares

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas
por: Yang, Yang, et al.
Publicado: (2021)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression
por: Ma, Kaiming, et al.
Publicado: (2021)

PDIA3 correlates with clinical malignant features and immune signature in human gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma
por: Takata, Hideyuki, et al.
Publicado: (2016)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
por: Sun, Jin-Zhang, et al.
Publicado: (2021)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches
por: Paglia, Giuliano, et al.
Publicado: (2021)

Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer
por: Wang, Ke, et al.
Publicado: (2017)

Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors
por: Zelencova-Gopejenko, D., et al.
Publicado: (2023)

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas
por: Zou, Hecun, et al.
Publicado: (2018)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

PDIA2 variant associated with vitiligo
por: Li, Fucheng, et al.
Publicado: (2023)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis
por: Ma, Kaiming, et al.
Publicado: (2022)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Expression and Prognostic Significance of PDIA3 in Cervical Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

The role of PDIA3 in myogenesis during muscle regeneration
por: Wang, Chao, et al.
Publicado: (2020)

CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance
por: Ma, Kaiming, et al.
Publicado: (2022)

ERp57/PDIA3: new insight
por: Chichiarelli, Silvia, et al.
Publicado: (2022)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

Knockdown of PDIA6 Inhibits Cell Proliferation and Enhances the Chemosensitivity in Gastric Cancer Cells
por: Yan, Chao, et al.
Publicado: (2020)

PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis
por: Han, Feng, et al.
Publicado: (2016)

CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas
por: Ma, Kaiming, et al.
Publicado: (2022)

Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma
por: Kuang, Xiao-yan, et al.
Publicado: (2015)

Increased Expression of Homeobox 5 Predicts Poor Prognosis: A Potential Prognostic Biomarker for Glioma
por: Xu, Chengran, et al.
Publicado: (2022)

Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
por: Wang, Xiucun, et al.
Publicado: (2020)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

DDX3X Biomarker Correlates with Poor Survival in Human Gliomas
por: Hueng, Dueng-Yuan, et al.
Publicado: (2015)

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
por: Chen, Yu, et al.
Publicado: (2022)

Impaired Bone Formation in Pdia3 Deficient Mice
por: Wang, Yun, et al.
Publicado: (2014)

Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma
por: Zhang, Hang, et al.
Publicado: (2013)

Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis
por: Wu, Changwu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ti93l4idbmm51cfkc8569gi0q